Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials

Abstract Recent clinical trials investigating cardiovascular (CV) safety of newer antidiabetic agents have been rapidly and largely changing the landscape of diabetes care and providing highly important clinical information on decision-making regarding the choice of antidiabetic agents. Similar to t...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Atsushi Tanaka, Koichi Node
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2018-06-01
coleção:	Cardiovascular Diabetology
Assuntos:	Type 2 diabetes Cardiovascular outcomes trial Glucagon-like peptide-1 receptor agonist Sodium-glucose cotransporter 2 inhibitor Major adverse cardiovascular event
Acesso em linha:	http://link.springer.com/article/10.1186/s12933-018-0731-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!